Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase EARLY_PHASE1 1

Status

Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

pembrolizumab 1255Specimen Handling 871Carboplatin 820Magnetic Resonance Spectroscopy 809Cyclophosphamide 799Cisplatin 719Nivolumab 645Paclitaxel 626Radiotherapy 565Gemcitabine 563Biopsy 532Bevacizumab 471Dexamethasone 435fludarabine 406Docetaxel 370venetoclax 365Oxaliplatin 362Fluorouracil 353Capecitabine 350atezolizumab 342Rituximab 329durvalumab 328Doxorubicin 314Radiosurgery 306Pemetrexed 303Drug Therapy 294Standard of Care 293Ipilimumab 288Etoposide 279Radiation 279

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × dupilumab × 1 year × Clear all
NCT06637306 2026-05-14

Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer

Icahn School of Medicine at Mount Sinai

Phase EARLY_PHASE1 Recruiting
15 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07277322 2026-04-29

Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases

Icahn School of Medicine at Mount Sinai

Phase 1/2 Not yet recruiting
24 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05013450 2025-12-17

Dupilumab_Metastatic NSCLC

Icahn School of Medicine at Mount Sinai

Phase 1/2 Active not recruiting
33 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡